Skip to content

A clinical trial to evaluate an investigational contact lens worn in an extended wear mode (7 days and 6 nights of extended wear)

Clinical Evaluation of an Investigational contact lens in 7-Day Extended Wear - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2011/06/001845
Enrollment
85
Registered
2011-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vision Correction

Interventions

Intervention1: galyfilcon A Contact Lens with Silver: One fresh pair of contact lenses worn weekly and replaced Control Intervention1: NIL: NIL

Sponsors

Johnson and Johnson Vision Care Inc
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A.Be between 18 and 39 years of age. B.Require a visual correction in both eyes (Monovision not allowed) C.Require a soft contact lens spherical correction between -0.50 and -5.75D in both eyes. D.Have an astigmatic correction less than 1.50D in both eyes. E.Be able to regularly wear the lenses on a 7 day/6 night extended wear basis (e.g. does not regularly swim more than once a week) F.Be correctable to a visual acuity of 20/30 or better in each eye with spherical distance correction. G.Have normal eyes with no evidence of abnormality or disease.

Exclusion criteria

Exclusion criteria: A.Requires concurrent ocular medication. B.Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear. C.Clinically significant (Grade 3 or 4) slit lamp findings including corneal edema, corneal vascularization, corneal staining, tarsal abnormalities, bulbar injection, or any other abnormality of the cornea that would contraindicate contact lens wear. D.Is currently or has previously worn any hard PMMA or RGP contact lenses. E.Known hypersensitivity to silver, silver ions or silver containing compounds.

Design outcomes

Primary

MeasureTime frame
First serious and significant Corneal infiltrative event with an investigational antimicrobial contact lens evaluated over a six-month wear period.Timepoint: Events within six-month wear period.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

Australia, India

Contacts

Public ContactRanganath R Raja

Johnson and Johnson Limited

rraja@its.jnj.com22542415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026